Search
Search Results
-
Systemic Disease and Portal Hypertension
Purpose of ReviewThe development of portal hypertension is typically a consequence of liver cirrhosis due mainly to primary liver disorders, whereas...
-
Portal Hypertension VII Proceedings of the 7th Baveno Consensus Workshop: Personalized Care in Portal Hypertension
This book, the seventh in a series of proceedings volumes that began in 1995, reviews the latest developments in the diagnosis and management of...
-
Management of Portal Hypertension in the Older Patient
Purpose of this reviewAging is a process of physiological slowing, reduced regenerative capacity and inability to maintain cellular homeostasis....
-
Diagnosis and Management of Noncirrhotic Portal Hypertension
Purpose of ReviewPorto-sinusoidal vascular disease (PSVD) refers to a group of vascular diseases of the liver with lesions encompassing the portal...
-
Portal Hypertension in Alcohol-Associated Hepatitis
Purpose of ReviewThis review article will examine portal hypertension in alcoholic hepatitis (AH) from both a basic mechanistic and a clinical...
-
Non-Cirrhotic Portal Hypertension: an Overview
Purpose of ReviewNon-cirrhotic portal hypertension (NCPH) is a broad term, which includes a heterogeneous group of disorders characterized by...
-
Alterations of the peptidomic composition of peripheral plasma after portal hypertension correction by transjugular intrahepatic portosystemic shunt
Portal hypertension develops in patients with advanced chronic liver diseases (CLD), especially cirrhosis and is associated with complications, such...
-
Interventional Radiology and Surgical Treatment Options for Non-Cirrhotic Portal Hypertension
Purposeof reviewNoncirrhotic portal hypertension (NCPH) consists of a heterogenous group of disorders that lead to portal hypertension (pHTN) in the...
-
Pharmacotherapies for Portal Hypertension: Current Status and Expanding Indications
PurposeNon-selective beta blockers remain the pharmacotherapy of choice for prevention of the first episode of variceal bleeding (primary prevention)...
-
Portal vein thrombosis, hepatic decompensation, and survival in patients with porto-sinusoidal vascular disease and portal hypertension
BackgroundPorto-sinusoidal vascular disease (PSVD) is a novel nomenclature to describe non-cirrhotic portal hypertension and characteristic histology...
-
CT perfusion imaging of the liver and the spleen can identify severe portal hypertension
PurposeTo determine if hepatic and splenic perfusion parameters are useful in identifying severe portal hypertension (SPH).
MethodsThe study...
-
Non-Cirrhotic Portal Hypertension in Children: Current Management Strategies
Purpose of ReviewNon-cirrhotic portal hypertension (NCPH) is primarily comprised of extrahepatic portal venous obstruction (EHPVO), followed by...
-
Emerging Therapeutic Targets for Portal Hypertension
Purpose of ReviewPortal hypertension is responsible of the main complications of cirrhosis, which carries a high mortality. Recent treatments have...
-
Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis
BackgroundCystic fibrosis (CF)–associated liver disease commonly manifests as portal hypertension and its complications. We investigated the proposal...
-
Non-invasive Assessment of Clinically Significant Portal Hypertension
Purpose of ReviewClinically significant portal hypertension (CSPH) is a serious clinical condition causing decompensation and potentially fatal...
-
Efficacy and safety of precision-guided transjugular extrahepatic portosystemic shunt (TEPS) in the management of cavernous transformation of the portal vein with portal hypertension: a case series
Background and aimsPerforming a Transjugular intrahepatic portal system shunt (TIPS) in patients with portal vein cavernous transformation (CTPV)...
-
Interventional Management of Portal Hypertension in Cancer Patients
Purpose of ReviewTo provide an overview of the classifications and clinical hallmarks of common cancer-related conditions that contribute to the high...
-
Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH)
AimIdiopathic non-cirrhotic portal hypertension (INCPH) is a vascular disorder of uncertain origin. Diagnosis can be challenging on liver biopsy....
-
Generalized crystal-storing histiocytosis with noncirrhotic portal hypertension: an autopsy case report
Crystal-storing histiocytosis (CSH) is a rare disease associated with the accumulation of histiocytes containing crystalline matter within their...
-
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
The Billroth IV consensus was developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian...
